| Targeting natural killer cells and natural killer T cells in cancer E Vivier, S Ugolini, D Blaise, C Chabannon, L Brossay Nature Reviews Immunology 12 (4), 239-252, 2012 | 1025 | 2012 |
| The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans CS Brandt, M Baratin, EC Yi, J Kennedy, Z Gao, B Fox, B Haldeman, ... Journal of Experimental Medicine 206 (7), 1495-1503, 2009 | 817 | 2009 |
| Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy R Moschoi, V Imbert, M Nebout, J Chiche, D Mary, T Prebet, E Saland, ... Blood, The Journal of the American Society of Hematology 128 (2), 253-264, 2016 | 404 | 2016 |
| Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. O Rosnet, HJ Bühring, S Marchetto, I Rappold, C Lavagna, D Sainty, ... Leukemia 10 (2), 238-248, 1996 | 358 | 1996 |
| DNAM-1 and PVR regulate monocyte migration through endothelial junctions N Reymond, AM Imbert, E Devilard, S Fabre, C Chabannon, L Xerri, ... The Journal of experimental medicine 199 (10), 1331-1341, 2004 | 326 | 2004 |
| Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 RF Duarte, M Labopin, P Bader, GW Basak, C Bonini, C Chabannon, ... Bone marrow transplantation 54 (10), 1525-1552, 2019 | 317 | 2019 |
| Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years JR Passweg, H Baldomero, C Chabannon, GW Basak, R de La Cámara, ... Bone marrow transplantation 56 (7), 1651-1664, 2021 | 301 | 2021 |
| A gene expression signature identifies two prognostic subgroups of basal breast cancer R Sabatier, P Finetti, N Cervera, E Lambaudie, B Esterni, E Mamessier, ... Breast cancer research and treatment 126, 407-420, 2011 | 274 | 2011 |
| Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow … I Yakoub-Agha, C Chabannon, P Bader, GW Basak, H Bonig, F Ciceri, ... haematologica 105 (2), 297, 2020 | 267 | 2020 |
| Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, GW Basak, ... Bone marrow transplantation 49 (7), 865-872, 2014 | 229 | 2014 |
| The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients … P Ljungman, M Mikulska, R de La Camara, GW Basak, C Chabannon, ... Bone marrow transplantation 55 (11), 2071-2076, 2020 | 228 | 2020 |
| Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen M Mohty, JO Bay, C Faucher, B Choufi, K Bilger, O Tournilhac, N Vey, ... Blood 102 (2), 470-476, 2003 | 223 | 2003 |
| Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open … B Granel, A Daumas, E Jouve, JR Harlé, PS Nguyen, C Chabannon, ... Annals of the rheumatic diseases 74 (12), 2175-2182, 2015 | 205 | 2015 |
| Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the … PJ Hayden, C Roddie, P Bader, GW Basak, H Bonig, C Bonini, ... Annals of Oncology 33 (3), 259-275, 2022 | 195 | 2022 |
| The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus JR Passweg, H Baldomero, C Chabannon, GW Basak, S Corbacioglu, ... Bone marrow transplantation 55 (8), 1604-1613, 2020 | 190 | 2020 |
| Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 JA Snowden, I Sánchez-Ortega, S Corbacioglu, GW Basak, C Chabannon, ... Bone marrow transplantation 57 (8), 1217-1239, 2022 | 187 | 2022 |
| The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies JR Passweg, H Baldomero, GW Basak, C Chabannon, S Corbacioglu, ... Bone marrow transplantation 54 (10), 1575-1585, 2019 | 180 | 2019 |
| Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy A Goncalves, B Esterni, F Bertucci, R Sauvan, C Chabannon, ... Oncogene 25 (7), 981-989, 2006 | 175 | 2006 |
| Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide L Castagna, R Crocchiolo, S Furst, S Bramanti, J El Cheikh, B Sarina, ... Biology of Blood and Marrow Transplantation 20 (5), 724-729, 2014 | 171 | 2014 |
| CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines G Zabouo, AM Imbert, J Jacquemier, P Finetti, T Moreau, B Esterni, ... Breast Cancer Research 11, 1-14, 2009 | 169 | 2009 |
